Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 EUR | -0.48% | -7.52% | -3.69% |
Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Performance
1 day | -0.48% | ||
Current month | -3.69% | ||
Current year | -3.69% | ||
3 years | -13.99% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.48% | -7.52% | -3.69% | - | 211M | ||
-0.47% | +15.77% | +25.69% | -3.95% | 47.86B | ||
+1.09% | -1.55% | +46.90% | -10.72% | 41.42B | ||
+0.55% | -4.90% | -3.46% | +19.44% | 40.66B | ||
+0.80% | +7.02% | -6.20% | +18.87% | 28.92B | ||
+2.64% | +0.23% | +9.17% | +66.35% | 25.55B | ||
+1.34% | +6.29% | -20.42% | -23.64% | 19.27B | ||
+0.38% | -0.85% | +28.07% | +91.05% | 12.14B | ||
+2.24% | +20.65% | +0.17% | -10.11% | 12.15B | ||
+1.56% | +1.94% | -1.24% | +21.94% | 11.99B | ||
+1.65% | +12.21% | +19.33% | +20.15% | 11.64B | ||
+0.70% | +3.19% | -4.01% | -7.23% | 9.53B | ||
+0.18% | +15.26% | +16.21% | +106.61% | 6.73B | ||
+2.58% | +11.79% | +40.17% | +68.69% | 6.85B | ||
-0.94% | +2.44% | +7.53% | -35.02% | 6.6B | ||
+1.64% | -0.92% | +23.62% | -16.39% | 6.66B | ||
Average | +0.97% | +6.58% | +11.12% | +20.40% | ||
Weighted average by Cap. | +0.91% | +5.27% | +13.18% | +14.59% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2022 | -2.69% | ||
2021 | -10.80% | ||
2020 | +66.67% | ||
2019 | -.--% |
- Stock Market
- Equities
- XLS Stock
- XLS Stock
- Quotes Xlife Sciences AG